Kevin Felpel

Advanced HF & Transplant Cardiologist WVU via @UofUCV, @UConnIM alum

[Navin Kapur @NavinKapur4]

To PAC or not to PAC that is the question the #PACCS #RCT will answer. The #CSWG announces enrollment of the first #HF patient <2 weeks after trial activation. This is the #Door2PAC RCT to address recent guideline changes for PAC use in #cardiogenicshock https://t.co/MFwK2jSxQz

[Ronald Witteles @Ron_Witteles]

2) Another nail in the coffin for #PCI improving #heartfailure outcomes. ABSOLUTELY no difference in death or HF hospitalization (p=0.96) with PCI, even despite viability testing. PCI is for angina & ACS, not heart failure! Now, will it change practice??? https://t.co/QZmJTf30lL

[Ronald Witteles @Ron_Witteles]

1) Another win for #SGLT2i in #HFpEF, this time for dapagliflozin. For those who quibble with the HFpEF definition (LVEF>40%), look at the subgroup analysis -- jut as impactful for patients with truly normal LVEFs as those with mild systolic dysfunction. https://t.co/Lw2Zfotqcf

[Johann Bauersachs @JBauersachsMD]

Congratulations to ⁦@WilfriedMullens⁩ for the execution of a fully academic study proving that addition of acetazolamide to furosemide is associated with better decongesting in decompensated #heartfailure‼️

⁦@escardio⁩ ⁦@ESCardioNews⁩ #cardiotwitter

[Journal of Cardiac Failure @JCardFail]

🌟NEW🌟 ACC/AHA/HFSA HEART FAILURE GUIDELINES!!!
👉https://t.co/P8z17pn0SE
Executive Summary
👉https://t.co/gdlXfKNePb

w/🔥EXCLUSIVE🔥 editorial: TAKE ���MESSAGES by the one & only @MKIttlesonMD!
👉https://t.co/IpMypiumtV

@HFSA @ACCinTouch @AHAScience @robmentz @dranulala

[Dmitry Yaranov @DmitryYaranovMD]

Hot off the press; pressures do not equal volume CMEMs+BVA in clinical practice @FudimMarat @docbhardwaj @RyanTedfordMD @docbhardwaj @rzw113 @SusanJosephMD @shelleyhallmd @amitalamMD @jljefferiesmd @LindenfeldJoann

[Josef Stehlik @JosefStehlik]

Pig-to-human heart #xenotransplant - important issues to be addressed, but it will be an exciting journey! https://t.co/5XrHBTM2aU
@ISHLT @UMmedschool @MaryjaneFarrMD @CircAHA @josephahill @JamesCFangMD @shelleyhallmd @SusanJosephMD @AMBertolotti @CAmarelli74 @LuPoten

[Anu Lala (Anuradha Lala-Trindade) @dranulala]

👉🏽Economic issues 💰in #FunctionNotFailure in the US - @HFSA review! Powerhouse- up to date paper OPEN @JCardFail 👇🏽👇🏽👇🏽

@robmentz @ShelleyZieroth @AndrewJSauer @haiderwarraich @gcfmd @rcstarling @DrNancySweitzer @ATSandhu @ShashankSinhaMD @noshreza
https://t.co/cjl8hkRe6A

[Kevin Felpel @felpel007]

@KevinShahMD @UofUCV @JosefStehlik @StavrosDrakos @JamesCFangMD @OmarWever @UofUHealth @IntermtnMedCtr @UUcvsl @KismetRasmu Thank you to all for an excellent year! It has been a privilege to train among the best and be part of the fantastic work being done in Utah. I’m sad to leave but excited to join faculty in HFTX @WVUMedicine!

[Stavros George Drakos @StavrosDrakos]

#UCARS21 One Week Away! Check out the Final Agenda & Register: https://t.co/5yRu0DZEXK

Innovative Original Abstracts & Guest Faculty! Keynote by Sir Magdi Yacoub!

@IntermtnMedCtr @JosefStehlik @tonkhueMdPhd @PalakShahMD @manreetkanwar @shelleyhallmd @behnam_tehrani @NavinKapur4

[U-CARS @UCARS_recovery]

An amazing line up of speakers once again for 2021 U-CARS- keynote by Sir Magdi Yacoub, MD, @NirUrielMD; @Abcatino ; @manreetkanwar ; @StavrosDrakos ; @JosefStehlik and many others!

[Kevin Felpel @felpel007]

CS is heterogeneous & tailored treatment to the specific phenotype guided by invasive hemodynamic monitoring when not improving/deteriorating is prudent. Not all CS is the same! PAC is an important diagnostic tool https://t.co/3JV0L62Whg

[Kevin Felpel @felpel007]

Excellent review of CS depicting regional referral systems for a standardized approach tailored to the specific phenotype and guided by invasive hemodynamic monitoring. Not all CS is the same!

[Alex Truesdell @agtruesdell]

2/2 Link to paper here: https://t.co/afblOt1VYU...

[Stavros George Drakos @StavrosDrakos]

Multicenter RESTAGE-HF @CircAHA, https://t.co/v4g2sCqtU2 47.5% LVAD Explants for #CardiacRecovery in pts w Baseline LV DILATION &⬇️EF! Excellent Outcomes 1 & 3 years Post-Explant! Explants in ALL sites:@UofUHealth @UofLHealth @PennMedicine @CvUnmc @MontefioreNYC @ClevelandClinic

[Kevin S Shah, MD @KevinShahMD]

Applying to #HeartFailure / Transplant Cardiology Fellowship?

Consider training with some of the best at UofUtah— We are eager to meet you (virtually)!

https://t.co/DaUxy6hJVb

@UUcvsl @JamesCFangMD @JosefStehlik @StavrosDrakos @OmarWever @JJRyanMD @LKemeyou @SHMcKellarMD